Peripartum Cardiomyopathy (PPCM)
๐ท Definition
Peripartum cardiomyopathy (PPCM) is a rare form of idiopathic dilated cardiomyopathy that occurs during the last month of pregnancy or within 5 months postpartum in previously healthy women, characterized by left ventricular systolic dysfunction.
๐ง Key Point: LV ejection fraction (LVEF) is <45% with or without left ventricular dilatation.
๐งช Diagnostic Criteria (as per NIH/European Society of Cardiology):
All 4 criteria must be met:
- Development of heart failure in the last month of pregnancy or within 5 months postpartum.
- Absence of another identifiable cause of heart failure.
- No prior history of heart disease.
- Echocardiographic evidence of LV systolic dysfunction:
- LVEF <45%, or
- LV fractional shortening <30%, or
- LV end-diastolic dimension >2.7 cm/mยฒ
๐ง Pathophysiology
Exact cause is unknown, but multiple hypotheses:
|
Theory |
Explanation |
|
Prolactin hypothesis |
Oxidative stress leads to cleavage of prolactin into a toxic 16 kDa fragment โ endothelial dysfunction, apoptosis |
|
Inflammatory/autoimmune |
โ Inflammatory cytokines (TNF-ฮฑ, IL-6), myocarditis |
|
Genetic susceptibility |
TTN gene mutations found in some cases |
|
Angiogenic imbalance |
โ VEGF and โ anti-angiogenic factors (sFLT1) โ myocardial ischemia |
|
Hemodynamic stress |
Pregnancy-induced volume overload + hormonal changes precipitate dysfunction |
โ ๏ธ Risk Factors
- Age > 30
- Multiparity
- African ethnicity
- Pregnancy-induced hypertension
- Pre-eclampsia/eclampsia
- Twin or multiple gestation
- Prolonged tocolysis
- Smoking, selenium deficiency, cocaine
๐ Clinical Features
|
System |
Symptoms |
|
Cardiovascular |
Dyspnea, orthopnea, PND, palpitations, chest pain |
|
Respiratory |
Cough, hemoptysis, pulmonary edema |
|
Systemic |
Fatigue, edema, ascites |
|
Neurological |
Syncope, altered sensorium (if cerebral hypoperfusion) |
|
Fetal |
Preterm delivery, IUGR, fetal demise (in severe maternal compromise) |
๐งช Investigations
|
Modality |
Findings |
|
ECG |
Non-specific: sinus tachycardia, T wave inversion, LVH |
|
Chest X-ray |
Cardiomegaly, pulmonary edema |
|
Echocardiography |
Dilated LV, โ LVEF <45%, โ FS, wall motion abnormalities |
|
BNP/NT-proBNP |
Elevated |
|
Cardiac MRI |
Assesses myocardial inflammation/fibrosis |
|
Labs |
CBC, LFTs, RFTs, troponins, D-dimer (rule out PE) |
๐ Differential Diagnosis
- Myocarditis
- Ischemic heart disease
- Pulmonary embolism
- Pre-eclampsia with pulmonary edema
- Takotsubo cardiomyopathy
- Thyrotoxic cardiomyopathy
๐ Prognosis
- Recovery in 50โ70% within 6 months
- Risk of mortality: 5โ20%
- Poor prognostic markers:
- EF <30%
- LVEDD >6 cm
- Delayed diagnosis
- Persistent dysfunction at 6 months
๐ง Management Principles
Multidisciplinary approach: Cardiology + Obstetrics + Anesthesiology + Critical Care
โ๏ธ Medical Management
|
Drug Class |
Preferred Agent |
|
Diuretics |
Furosemide (relieves pulmonary congestion) |
|
Vasodilators |
Hydralazine, nitrates (โ afterload) |
|
Beta-blockers |
Metoprolol, bisoprolol (AVOID if acute decompensation) |
|
ACE Inhibitors/ARBs |
ONLY postpartum, contraindicated during pregnancy |
|
Digoxin |
Inotropic support, rate control |
|
Anticoagulation |
Consider if EF <35%, thrombus, arrhythmia |
|
Ivabradine |
HR control if ฮฒ-blockers not tolerated |
|
Bromocriptine |
Experimental; inhibits prolactin release โ shown to aid recovery in some studies |
๐ Advanced Therapies
- ICU monitoring if pulmonary edema, arrhythmia, or shock
- Mechanical ventilation if severe respiratory distress
- Inotropes (dobutamine, milrinone) if cardiogenic shock
- LVAD or heart transplant for refractory cases
๐ฌ Viva Q&A
Q: What is the role of bromocriptine in PPCM?
๐จ๏ธ Inhibits prolactin secretion โ reduces formation of toxic 16 kDa prolactin โ may help recovery.
Q: Why avoid ACE inhibitors in pregnancy?
๐จ๏ธ Risk of fetal renal agenesis, oligohydramnios, IUGR, death.
Q: What is the risk of recurrence in next pregnancy?
๐จ๏ธ 20โ50% if recovered EF; >60% if EF <50% postpartum. Recurrence can be fatal.
๐ MCQ Pearls
- Earliest sign of PPCM: Fatigue and dyspnea
- Treatment during pregnancy: Beta-blockers + hydralazine + diuretics
- Postpartum ACE inhibitor of choice: Enalapril
- Most dangerous complication: Cardiogenic shock
- Definitive treatment in refractory case: Heart transplant

